CATX logo

Perspective Therapeutics (CATX) Company Overview

Profile

Full Name:

Perspective Therapeutics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

November 10, 2005

Indexes:

Not included

Description:

CATX, a subsidiary of Perspective Therapeutics, focuses on developing innovative cancer treatments. The company aims to improve patient outcomes through advanced therapies and personalized medicine, leveraging cutting-edge technology to target tumors effectively while minimizing side effects. Their mission is to enhance the quality of life for cancer patients.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 17, 2024

Analyst ratings

Recent major analysts updates

Jan 14, 25 RBC Capital
Outperform
Nov 25, 24 RBC Capital
Outperform
Nov 25, 24 B of A Securities
Neutral
Nov 22, 24 Oppenheimer
Outperform
Oct 24, 24 Wedbush
Outperform
Oct 24, 24 UBS
Buy
Oct 11, 24 Oppenheimer
Outperform
Oct 1, 24 Wedbush
Outperform
Sep 25, 24 Truist Securities
Buy
Sep 10, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Perspective Therapeutics?
  • Does Perspective Therapeutics pay dividends?
  • What sector is Perspective Therapeutics in?
  • What industry is Perspective Therapeutics in?
  • What country is Perspective Therapeutics based in?
  • When did Perspective Therapeutics go public?
  • Is Perspective Therapeutics in the S&P 500?
  • Is Perspective Therapeutics in the NASDAQ 100?
  • Is Perspective Therapeutics in the Dow Jones?
  • When was Perspective Therapeutics's last earnings report?
  • When does Perspective Therapeutics report earnings?
  • Should I buy Perspective Therapeutics stock now?

What is the ticker symbol for Perspective Therapeutics?

The ticker symbol for Perspective Therapeutics is NYSE American:CATX

Does Perspective Therapeutics pay dividends?

No, Perspective Therapeutics does not pay dividends

What sector is Perspective Therapeutics in?

Perspective Therapeutics is in the Healthcare sector

What industry is Perspective Therapeutics in?

Perspective Therapeutics is in the Medical Devices industry

What country is Perspective Therapeutics based in?

Perspective Therapeutics is headquartered in United States

When did Perspective Therapeutics go public?

Perspective Therapeutics's initial public offering (IPO) was on November 10, 2005

Is Perspective Therapeutics in the S&P 500?

No, Perspective Therapeutics is not included in the S&P 500 index

Is Perspective Therapeutics in the NASDAQ 100?

No, Perspective Therapeutics is not included in the NASDAQ 100 index

Is Perspective Therapeutics in the Dow Jones?

No, Perspective Therapeutics is not included in the Dow Jones index

When was Perspective Therapeutics's last earnings report?

Perspective Therapeutics's most recent earnings report was on Nov 12, 2024

When does Perspective Therapeutics report earnings?

The next expected earnings date for Perspective Therapeutics is Mar 28, 2025

Should I buy Perspective Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions